Review
Published on 22 Jun 2023
Aortic dissection induced by vascular endothelial growth factor inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189910
- 2,994 views
- 4 citations
Type at least 3 characters
2,602 articles
Articles
Review
Published on 21 Jun 2023
Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170591
- 2,187 views
Editorial
Published on 21 Jun 2023
Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1227996
- 1,251 views
- 1 citation
Review
Published on 20 Jun 2023
Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1194861
- 3,204 views
- 8 citations
Systematic Review
Published on 20 Jun 2023
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1149138
- 4,714 views
- 7 citations
Original Research
Published on 20 Jun 2023
Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1217488
- 4,418 views
- 5 citations
Systematic Review
Published on 20 Jun 2023
Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1172969
- 4,393 views
- 2 citations
Editorial
Published on 19 Jun 2023
Editorial: Targeting oxidative stress in cancer: what is new in the prevention, diagnostic, treatment and prognostic strategies?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1229785
- 1,624 views
Editorial
Published on 19 Jun 2023
Editorial: Natural products modulate the sensitivity of cancer to anti-PD-1 based immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1232456
- 1,704 views
Case Report
Published on 16 Jun 2023
BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1141311
- 1,870 views
- 1 citation
Original Research
Published on 15 Jun 2023
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191262
- 4,489 views
- 11 citations
Original Research
Published on 15 Jun 2023
Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1098915
- 3,347 views
- 4 citations
Review
Published on 15 Jun 2023
Paraptosis: a unique cell death mode for targeting cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159409
- 13,415 views
- 41 citations
Editorial
Published on 15 Jun 2023
Editorial: Molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1236158
- 1,297 views
Opinion
Published on 15 Jun 2023
Artemisitene: a promising natural drug candidate with various biological activities needs to confirm the interactional targets
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1221291
- 14,522 views
- 3 citations
Original Research
Published on 14 Jun 2023
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200114
- 4,672 views
- 5 citations